Mirena®, Microgynon® and Yasmin® are registered trademarks of Bayer plc. Norimin® is a registered trademark of Pfizer Limited. Lucette® and Rigevidon® are registered trademarks of Consilient Health. Utrogestan® is a registered trademark of Besins Healthcare (UK) Ltd.
Viatris HRT Treatment Navigator
An individual menopausal woman needs an individual HRT treatment.
For women with an indication for HRT, this tool will help you tailor
individual therapy, from Viatris' broad range of treatment options, to
suit the individual patient.
Reporting of adverse reactions: Please continue to report suspected adverse drug reactions with any medicine or vaccine to the MHRA through the Yellow Card Scheme. It is easiest and quickest to report adverse drug reactions online via the Yellow Card website: https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the Google Play or Apple App Store. Alternatively, you can report via some clinical IT systems (EMIS/SystmOne/Vision/MiDatabank) or by calling the Commission on Human Medicines (CHM) free phone line:0800-731-6789. Adverse reactions/events should also be reported to MAH at e-mail address: firstname.lastname@example.org.
Viatris, Viatris UK Healthcare Limited, Building 4, Trident Place, Mosquito Way, Hatfield, Hertfordshire, AL10 9UL, United Kingdom.
Tel: +44 (0)1707 853000. For general enquiries please contact us on email: email@example.com.
This website is intended for UK healthcare professionals only.